An observational cohort study of EXTENDed dosing (Q2W or QM) with Aranesp® s.c. in subjects with Chronic Kidney Disease not on dialysis.

Sponsor ID

20060426

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 4

Product

darbepoetin alfa

Type

Observational

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.